Psychedelics for Depression & Anxiety
To the the UK Ministers for Drug Policy and Mental Health,
We call on you to reschedule the psychedelic substance psilocybin from Schedule 1 to Schedule 2.
4 million people suffer from depression & anxiety in the UK1. Research has shown the potential of psilocybin to treat these conditions2, 3, 4, 5, 6, yet it is being hindered by the restrictive Schedule 1 status of the substance.
The UK's drug scheduling system (Schedules 1-5) is separate from its classification system (Classes A-C)7. The Class of a drug affects the maximum penalty for an offence involving the drug, whilst the Schedule determines the regulations on its use in research and medicine.
Psilocybin is currently a Schedule 1 substance. Schedule 1 substances are not authorised for medical use and can only be supplied, possessed or administered in exceptional circumstances under a special Home Office licence. This means they cannot be prescribed by doctors, and that conducting research with them is extremely time-consuming and expensive.
By rescheduling psilocybin from Schedule 1 to Schedule 2, research would become faster and cheaper, and doctors would be able to start prescribing the substance when they see fit.
Out of compassion for those suffering from depression & anxiety, we ask that you take immediate action to reschedule psilocybin.
Reasons for signing
Sign this petition
759 needed to reach 6,000